Nitric Oxide Signaling and Soluble Guanylate Cyclase

一氧化氮信号传导和可溶性鸟苷酸环化酶

• 批准号: 7317430
• 负责人: MICHAEL A. MARLETTA
• 金额: $ 22.25万
• 依托单位: UNIVERSITY OF CALIFORNIA BERKELEY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-08-01 至 2009-07-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7317430
• 关键词: Agonist; Allosteric Site; Binding Sites; Biochemical; Clinical; Collaborations; Development; Disease; Dissociation; Electronics; Electrons; Enzyme Activation; Enzymes; Goals; Health; Heart; Heme; Heme Iron; Human; Human Biology; Impotence; Kinetics; Ligands; Maps; Methods; Modeling; Molecular; Molecular Biology; Nature; Nitric Oxide; Nitric Oxide Signaling Pathway; Nitric Oxide Synthase; Nucleotides; Physiological; Prevention; Proteins; Pulmonary Hypertension; Research; Research Design; Role; Septic Shock; Signal Transduction; Site; Soluble Guanylate Cyclase; Spectrum Analysis; Structure; Therapeutic Agents; absorption; base; design; human disease; inhibitor/antagonist; male; novel; protein protein interaction; research study; tool

DESCRIPTION (provided by applicant): The broad, long-term objectives of this proposal are: 1) To develop a complete molecular level view of soluble guanylate cyclase (sGC) activation and deactivation by nitric oxide (NO), and 2) To provide a rational basis for the understanding and treatment of human disease through the manipulation of NO. The specific aims are: 1) The characterization of NO activation and deactivation of sGC, including the nature of the second NO binding site, 2) The characterization of the nucleotide allosteric site, including the role of this site in modulating NO activation of the enzyme, 3) The mapping of the (a) intramolecular and (b) intermolecular protein-protein interactions that are important for sGC function, 4) To develop novel alkyl-NO ligands that are specific for the iron-heme binding site, to be used as spectroscopic probes, potential agonists and/or antagonists, and tools to help identify non-heme NO binding sites, and 5) obtain a crystal structure of sGC. The research design and methods for achieving these goals will be the use of basic molecular biology to acquire purified protein. Then, sGC function will be investigated with biochemical methods, including activity experiments and electronic absorption, resonance Raman, and electron paramagnetic spectroscopy. These studies are directed towards the development of a physiological model of sGC function. Understanding this function is critical for the design of therapeutic agents to treat diseases that involve the NO signaling pathway. Nitric oxide and nitric oxide synthase inhibitors are in clinical use in the treatment of diseases such as septic shock, pulmonary hypertension, male impotence, and angina pectortis. New therapies based on the manipulation of NO function in human biology will continue to have significant impact on human health and disease treatment/prevention. The proposed research examines the details of NO activation of sGC, the heart of this manipulation.

描述（由申请人提供）：该提案的广泛，长期目标是：1）开发可溶性鸟苷酸环化酶（SGC）激活的完整分子水平视图，并通过一氧化氮（NO）和2）提供通过操纵NO的理解和治疗人类疾病的合理基础。具体目的是：1）NO激活和SGC失活的表征，包括第二个无结合位点的性质，2）核苷酸变构位点的表征，包括该位点在调节酶无激活中的作用，3）（a）分子内和（b）对SGC功能很重要的分子内和（b）分子间蛋白 - 蛋白质相互作用，4）开发新的烷基-NO配体，这些配体是特定于铁 - - 铁 - 结合位点的，用于使用作为光谱探针，潜在的激动剂和/或拮抗剂，以及有助于识别非血红素无结合位点的工具，5）获得SGC的晶体结构。实现这些目标的研究设计和方法将是使用基本的分子生物学来获取纯化的蛋白质。然后，将使用生化方法研究SGC功能，包括活性实验和电子吸收，共振拉曼和电子顺磁性光谱。这些研究针对SGC功能的生理模型的发展。了解此功能对于设计涉及无信号通路的疾病的治疗剂的设计至关重要。一氧化氮和一氧化氮合酶抑制剂用于治疗诸如败血性休克，肺动脉高压，雄性阳ot和心绞痛等疾病。基于操纵人类生物学功能的新疗法将继续对人类健康和疾病治疗/预防产生重大影响。拟议的研究研究了没有激活SGC的细节，SGC是这种操纵的核心。